Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol : the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study
収録刊行物
-
- J Am Coll Cardiol
-
J Am Coll Cardiol 45 712-719, 2005